Imran Siddiqui

Dr. Imran Siddiqui

University of Lausanne, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Immunity
Verified
Journal Article
Closed access
ISImran Siddiqui
Imran Siddiqui
KSKarin Schaeuble
Karin Schaeuble
VCVijaykumar Chennupati
Vijaykumar Chennupati
SMSilvia A. Fuertes Marraco
Silvia A. Fuertes Marraco
SCSandra Calderon-Copete
Sandra Calderon-Copete
WHWerner Held
Werner Held

24 May 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YGYugang Guo
Yugang Guo
YXYu-Qing Xie
Yu-Qing Xie
MGMin Gao
Min Gao
YZYang Zhao
Yang Zhao
FFFabien Franco
Fabien Franco
LTLi Tang
Li Tang

1 November 2020 in Immunity
Verified
Journal Article
Closed access
DFDaniela Pais Ferreira
Daniela Pais Ferreira
JSJoana Gomes Silva
Joana Gomes Silva
TWTania Wyss
Tania Wyss
SMSilvia A. Fuertes Marraco
Silvia A. Fuertes Marraco
LSLéonardo Scarpellino
Léonardo Scarpellino
WHWerner Held
Werner Held

15 November 2009 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SNShiny Nair
Shiny Nair
PRPoongothai A Ramaswamy
Poongothai A Ramaswamy
SGSudip Ghosh
Sudip Ghosh
DJDhananjay C. Joshi
Dhananjay C. Joshi
NPNiteen Pathak
Niteen Pathak
MSMukhopadhyay Sangita
Mukhopadhyay Sangita
The pathophysiological functions of proline-glutamic acid (PE)/proline-proline-glutamic acid (PPE) family of proteins of Mycobacterium tuberculosis are not well understood. In this study, we demonstrate that one of the PPE proteins, PPE18 can stimulate macrophages to secrete IL-10, known to favor a Th2 type response. The recombinant PPE18 was found to specifically interact with the TLR2 leading to an early and sustained activation of p38 MAPK, which is critical for IL-10 induction. In silico docking analyses and mutation experiments indicate that PPE18 specifically interacts with the leucine rich repeat 11∼15 domain of TLR2 and the site of interaction is different from that of a synthetic lipopeptide Pam3CSK4 known to activate predominantly ERK 1/2. When PMA-differentiated THP-1 macrophages were infected with a mutant Mycobacterium tuberculosis strain lacking the PPE18, produced poorer levels of IL-10 as compared with those infected with the wild-type strain. In contrast, an M. smegmatis strain overexpressing the PPE18 induced higher levels of IL-10 in infected macrophages. Our data indicate that the PPE18 protein may trigger an anti-inflammatory response by inducing IL-10 production.

10 November 2011 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SCSamit Chatterjee
Samit Chatterjee
VDVed Prakash Dwivedi
Ved Prakash Dwivedi
YSYogesh Singh
Yogesh Singh
ISImran Siddiqui
Imran Siddiqui
PSPawan Sharma
Pawan Sharma
GDGobardhan Das
Gobardhan Das
Despite its relatively poor efficacy, Bacillus Calmette-Guérin (BCG) has been used as a tuberculosis (TB) vaccine since its development in 1921. BCG induces robust T helper 1 (Th1) immune responses but, for many individuals, this is not sufficient for host resistance against Mycobacterium tuberculosis (M. tb) infection. Here we provide evidence that early secreted antigenic target protein 6 (ESAT-6), expressed by the virulent M. tb strain H37Rv but not by BCG, promotes vaccine-enhancing Th17 cell responses. These activities of ESAT-6 were dependent on TLR-2/MyD88 signalling and involved IL-6 and TGF-β production by dendritic cells. Thus, animals that were previously infected with H37Rv or recombinant BCG containing the RD1 region (BCG::RD1) exhibited improved protection upon re-challenge with virulent H37Rv compared with mice previously infected with BCG or RD1-deficient H37Rv (H37RvΔRD1). However, TLR-2 knockout (TLR-2-/-) animals neither showed Th17 responses nor exhibited improved protection in response to immunization with H37Rv. Furthermore, H37Rv and BCG::RD1 infection had little effect on the expression of the anti-inflammatory microRNA-146a (miR146a) in dendritic cells (DCs), whereas BCG and H37RvΔRD1 profoundly induced its expression in DCs. Consistent with these findings, ESAT-6 had no effect on miR146a expression in uninfected DCs, but dramatically inhibited its upregulation in BCG-infected or LPS-treated DCs. Collectively, our findings indicate that, in addition to Th1 immunity induced by BCG, RD1/ESAT-6-induced Th17 immune responses are essential for optimal vaccine efficacy. Tuberculosis is a global health problem, with one-third of the global population infected with tubercle bacteria. Numerous studies have shown that Th1 cell responses are indispensable for protective immunity against TB. However, while the vaccine strain BCG induces sufficient Th1 cell response, this response does not appear to be sufficient for immune protection in many individuals. Here, we provide evidence for the first time that Th17 cell responses in the lung play a critical role for enhanced protection against TB. Surprisingly, the virulent M. tb strain H37Rv induced Th17 cell responses in the lung. Consequently, antibiotic-treated animals that were previously infected with H37Rv, as compared with similarly treated BCG-infected mice, generated improved protective immune responses against infection with virulent M. tb. We also provide evidence that the ESAT-6 protein, which is absent in BCG but present in H37Rv, induces IL-6 and TGF-β in dendritic cells in a TLR-2 and MyD88-dependent manner, which generates an environment that is conducive for the differentiation of Th17 cells in the lung. Our findings indicate that, in addition to Th1 cells, Th17 cells play a critical role in conferring optimal protection against TB.

1 June 2013 in Immunity
Verified
Journal Article
Closed access
SSShahin Shafiani
Shahin Shafiani
CDCrystal Dinh
Crystal Dinh
JEJames M. Ertelt
James M. Ertelt
AMAlbanus O. Moguche
Albanus O. Moguche
ISImran Siddiqui
Imran Siddiqui
KUKevin B. Urdahl
Kevin B. Urdahl